SLN
Silence Therapeutics PLC
10.60$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -174.1% | -565.3% | -58.2% | -904.5% | -1,721.2% | -81.7% | -6,700.4% | -7,091.2% | -6,849.7% | -50,844.1% | -3,703.6% | – | -6,883.8% | |
| 4.5% | 5.8% | 1.0% | 25.1% | 10.1% | 0.5% | 75.1% | 48.2% | 98.1% | 1,497.1% | 17.1% | – | 131.9% | |
| 137.7% | 71.7% | 26.2% | 692.5% | 271.1% | 14.1% | 1,491.6% | 678.7% | 1,594.3% | 21,394.7% | 580.8% | – | 2,208.1% | |
| 131.2% | -54.0% | -65.8% | 1,828.3% | 22.2% | -108.2% | 3,672.6% | -1,465.5% | 3,278.0% | -10,749.3% | -629.1% | – | 1,900.6% | |
| 0.7% | 0.0% | 0.0% | 14.2% | 4.3% | 0.2% | 2.2% | 15.6% | 1.9% | 161.8% | 0.0% | – | 9.4% | |
| 737.2% | 18.2% | -317.9% | -7.2% | -2,525.5% | 223.8% | -24,158.7% | -508.5% | 32,257.2% | -156,876.5% | 2,373.7% | – | 11,866.3% | |
| – | – | – | – | -6.4% | – | – | – | – | – | – | – | – | |
| 430.0% | 472.6% | 847.3% | 199.5% | 522.6% | -27.3% | 7.6% | 0.3% | 0.0% | 0.0% | 0.0% | – | 0.3% | |
| 1,039.7% | -227.8% | 470.9% | -714.5% | -4,161.9% | 143.4% | -30,725.2% | -7,534.9% | 25,340.9% | -208,100.0% | -1,330.0% | – | 4,937.7% | |
| -174.8% | -565.4% | -58.2% | -918.7% | -1,725.5% | -102.4% | -6,702.6% | -7,106.8% | -6,851.6% | -51,005.9% | -3,703.6% | – | -6,893.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.